This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Ask the Experts: How to have an effective INTERACT meeting with the FDA
Published on: Mar 1st, 2021
INTERACT meeting is an informal non-binding consultation with the CBER at FDA. It allows sponsors to obtain preliminary informal consultation for innovative investigational products at an early stage of development on issues that are not yet at the pre-IND meeting phase.
Although this meeting is highly recommended by FDA, an INTERACT meeting is not an FDA requirement.
In this “Ask the Expert” session, you can ask any questions you may have with regards to this meeting, such as:
– Why request an INTERACT meeting?
– At what point in pre-clinical development should an INTERACT meeting be requested
– What does the INTERACT program involve/consist of?
– What should I expect after an INTERACT meeting is requested?
SAMPLE OF THE WEBINAR
Teaser Ask the Experts How to have an effective INTERACT meeting with the FDA
Access the full webinar replay now
Fill in the form to download the content